BILD 1633 SE
Latest Information Update: 24 Sep 2012
Price :
$50 *
At a glance
- Originator Boehringer Ingelheim (Canada)
- Class Antivirals
- Mechanism of Action Ribonucleotide reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections